SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-075010
Filing Date
2023-09-07
Accepted
2023-09-07 16:32:10
Documents
1
Period of Report
2023-09-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3905
  Complete submission text file 0001213900-23-075010.txt   5274
Mailing Address C/O KADMON HOLDINGS, LLC 450 E. 29TH STREET NEW YORK NY 10016
Business Address
Ryan John L (Reporting) CIK: 0001679825 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40582 | Film No.: 231242674

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Issuer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations